SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Achyut Healthcare Ltd (543499)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543499 NSE: Trading | Small Cap | Achyut Healthcare Share Price

₹8.44 0.35 (4.33%)

As on 02-Jul'26 16:59

Achyut Healthcare Ltd (543499)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543499 NSE: Trading | Small Cap | Achyut Healthcare Share Price

₹8.44 0.35 (4.33%)

As on 02-Jul'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹195 Cr.
Current Price
₹8.4
52-Week Low / High
₹4 / 10
TTM EPS
₹0
TTM Sales
₹11.6 Cr.
Book Value per Share
₹1.5
P/E Ratio
615.96
Higher than its 5-year historical median
Industry PE
38.3
Price to Book (P/B)
5.57
Higher than its 5-year historical median
Price to Sales (P/S)
16.84
Lower than its 5-year historical median
EV/EBITDA
348.40
Higher than its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
1.77%
Underperforms industry median
Return on Capital Employed (ROCE)
2.27%
Underperforms industry median
Return on Assets (ROA)
1.72%
Operating Profit Margin
-6.2%
Net Profit Margin
17.97%
Gross Profit Margin
23.6%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
-50.33%
Operating Profit Growth (1 Year)
-
-766.67%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
10%
Asset Quality
Promoter Holding
47.40%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹11 Cr.
Equity
₹24.1 Cr.
Face Value
₹1
All Time Low / High
₹0.71 / 10.04

Achyut Healthcare stock performance

Key Ratios
mw4me loader

Check Before You Invest

Valuation

Overvalued

Price Trend

Weak
Q.1 Is Achyut Healthcare Ltd a good quality company?
Achyut Healthcare Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Achyut Healthcare Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Achyut Healthcare Ltd vs industry peers?
Achyut Healthcare Ltd revenue CAGR is 56.01%, compared to the industry median CAGR of 0%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of Achyut Healthcare Ltd?
Promoters hold 47.40% of the Achyut Healthcare Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Achyut Healthcare Ltd over the last decade?
Over the last 3 year(s), the stock has delivered a CAGR of 15.76% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Achyut Healthcare Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 7.2%9.5%5.6%2.2%2.6%3.3%2.3%-
Value Creation
Index
-0.5-0.3-0.6-0.9-0.8-0.8-0.8-

Growth Parameters

Sales 0.70.30.34.12.76.13.112
Sales YoY Gr.--50.8%-18.2%1,400%-33.3%127.4%-50.3%-
Adj EPS -00000000
YoY Gr.-NA0%-100%NA100%0%-
BVPS (₹) 0.20.20.30.60.71.31.31.5
Adj Net
Profit
-00000.20.50.60
Cash Flow from Ops. -0-00-7-0.4-0.4-4.1-
Debt/CF from Ops. 0000000-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales NA56%-9%-50.3%
Adj EPS NA14.9%NA0%
BVPSNA44.7%27.6%1.5%
Share Price - - 39% 122.1%

Key Financial Parameters

Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
-7.53.24.60.922.21.80.7
Op. Profit
Mgn %
2.12.34.2-1-10.10.4-6.21.1
Net Profit
Mgn %
-2.223.918.68.118.32.1
Debt to
Equity
00000000
Working Cap
Days
02484703781,2339402,079287
Cash Conv.
Cycle
01052152151544242

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales1004363
Operating Expenses + 1004363
Manufacturing Costs0000000
Material Costs1003263
Employee Cost 0000000
Other Costs 0001100
Operating Profit 000-0-00-0
Operating Profit Margin (%) 2.1%2.3%4.1%-0.9%-10.2%0.4%-6.6%
Other Income + 0000111
Exceptional Items 0000000
Interest 0000000
Depreciation 0000000
Profit Before Tax 0000011
Tax 0000000
Profit After Tax -0000011
PAT Margin (%) -2.2%4.2%3.9%1.0%8.6%8.2%18.0%
Adjusted EPS (₹)-0.00.00.00.00.00.00.0
Dividend Payout Ratio (%)0%0%0%0%0%0%0%

Valuation of Achyut Healthcare - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 0009153131
Share Capital 000791724
Reserves -0-0025148
Debt +0000000
Long Term Debt0000000
Short Term Debt0000000
Minority Interest0000000
Trade Payables0000001
Others Liabilities 00-00100
Total Liabilities 00010153133

Fixed Assets

Net Fixed Assets +0000000
Gross Block0000000
Accumulated Depreciation0000000
CWIP 00003918
Investments 0002100
Inventories0000000
Trade Receivables0000001
Cash Equivalents flag 0000001
Others Assets 0008102112
Total Assets 00010153133

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + -0-00-7-0-0-4
PBT 0000011
Adjustment -000-0-1-1-1
Changes in Working Capital -0-00-7-0-0-4
Tax Paid 0-00-0-0-0-0
Cash Flow From Investing Activity + 000-2-5-155
Capex 000-0-3-6-11
Net Investments 000-2-3-1115
Others 0000121
Cash Flow From Financing Activity + 00095160
Net Proceeds from Shares 00095160
Net Proceeds from Borrowing 0000000
Interest Paid 0000000
Dividend Paid 0000000
Others 0000000
Net Cash Flow -0-000-001

Financial Ratio

PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)N/AN/AN/A0.861.962.221.77
ROCE (%)N/AN/AN/A2.172.643.292.27
Asset Turnover Ratio2.891.330.740.780.210.270.1
PAT to CFO Conversion(x)N/AN/AN/AN/AN/A-0-4
Working Capital Days
Receivable Days53.30145.60300.7021.5031.7020.40105.10
Inventory Days00128.401030.1011.1014.60
Payable Days15.9071.20225.1033.9063.8016.3083.50

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Achyut Healthcare Ltd FAQs

The current trading price of Achyut Healthcare on 02-Jul-2026 16:59 is ₹8.44.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jul-2026 the market cap of Achyut Healthcare stood at ₹195.3 Cr

The latest P/E ratio of Achyut Healthcare as of 01-Jul-2026 is 616.0.

The latest P/B ratio of Achyut Healthcare as of 01-Jul-2026 is 5.57.

The 52-week high of Achyut Healthcare is ₹10.04 and the 52-week low is ₹3.55.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Achyut Healthcare is ₹11.60 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Achyut Healthcare Ltd is a below average quality company.

The key valuation ratios of Achyut Healthcare Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Achyut Healthcare Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Achyut Healthcare Ltd

Achyut Healthcare is engaged in the trading of Pharmaceutical Products. The company has business operations in both domestic and international markets in the countries namely UAE, Kenya, and Nigeria. The company is located in Ahmedabad, Gujarat. Since incorporation, it was the company‘s vision and mission has been to remained focused towards the pharmaceutical business of trading and supplying of superior quality products to its customers based on their customizations and requirements, which has enabled it to expand its business operations globally and dive into manufacturing business on its own plants rather than outsourcing and procuring from third parties.

Business area of the company

The company is engaged in trading of Cenzure, Arpimune, Azathioprine IP, Everomimus, Mycophenolate Mofetil USP, Mycophenolate Sodium USP, Sirolimus, Tacrolimus USP, Infrared thermometer, Ascorbic Acid Coated Vitamin C, Calcium carbonate oyster, Cellulose acetate Phthalate, Chlorthalidone IP, Cross Carmalose Sod IP/USP, DI Basic Calcium Phosphate IP, DI Ethyl Phthlate, Diltiazem Hydrochloride IP, Easy Coat Fc Titanium Dioxide, Escitalopram IP, Escitalopram Oxalate, Favipiravir among many other products.

Major Events and Milestones

  • January 11, 1996: The company was incorporated as a private limited company.
  • October 21, 2002: The name of Company was changed from ‘Achyut Securities Private Limited’ to ‘Achyut Healthcare Private Limited’.
  • November 30, 2021: The Company was converted into a public limited company.
You have 4 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: